External Quality Assessment 2.0: The Importance of a Standardized Implementation of TILs for Daily and Trial Practices
- Author(s)
- Nauwelaers, I; Laudus, N; Peeters, D; Acs, B; Denkert, C; Michiels, S; Horlings, H; Siziopikou, KP; Ely, S; Zardavas, D; Mustimbo, R; Bartlett, J; Floris, G; Hartman, J; van Deurzen, CHM; Ceusters, D; Dequeker, E; Salgado, R;
- Details
- Publication Year 2022,Volume 14,Issue #15,Page 3762
- Journal Title
- Cancers
- Publication Type
- Commentary
- Abstract
- Increasing data suggests that an intact immune system is required for improvedoutcomes in patients with Human Epidermal Growth Factor Receptor 2 (HER2+) and Triple Negative Breast Cancer (TNBC) [...].
- Department(s)
- Laboratory Research
- PubMed ID
- 35954426
- Publisher's Version
- https://doi.org/10.3390/cancers14153762
- Open Access at Publisher's Site
https://doi.org/10.3390/cancers14153762- Terms of Use/Rights Notice
- Refer to copyright notice on published article.
Creation Date: 2025-02-07 07:02:35
Last Modified: 2025-02-07 07:06:52